Dr. Shefali Shah, M.D

NPI: 1720469950
Total Payments
$3,392
2024 Payments
$1,685
Companies
27
Transactions
168
Medicare Patients
1,143
Medicare Billing
$131,971

Payment Breakdown by Category

Food & Beverage$3,256 (96.0%)
Education$115.90 (3.4%)
Other$20.00 (0.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,256 164 96.0%
Education $115.90 3 3.4%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $20.00 1 0.6%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $787.66 33 $0 (2024)
PFIZER INC. $323.97 19 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $311.11 18 $0 (2024)
QOL Medical, LLC $300.08 18 $0 (2024)
Janssen Biotech, Inc. $251.62 10 $0 (2024)
GENZYME CORPORATION $187.61 10 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $177.59 12 $0 (2024)
Regeneron Healthcare Solutions, Inc. $155.69 9 $0 (2024)
Covidien LP $125.00 1 $0 (2019)
Medtronic, Inc. $116.67 2 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,685 93 ABBVIE INC. ($386.42)
2023 $545.49 34 Regeneron Healthcare Solutions, Inc. ($85.81)
2022 $878.58 35 ABBVIE INC. ($339.54)
2021 $14.99 1 VIVUS LLC ($14.99)
2020 $53.08 3 Olympus America Inc. ($27.32)
2019 $125.00 1 Covidien LP ($125.00)
2017 $89.77 1 Alexion Pharmaceuticals, Inc. ($89.77)

All Payment Transactions

168 individual payment records from CMS Open Payments — Page 1 of 7

Date Company Product Nature Form Amount Type
12/20/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $22.17 General
Category: Immunology
12/18/2024 Janssen Biotech, Inc. TREMFYA (Drug), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $16.43 General
Category: Immunology
12/16/2024 ABBVIE INC. CREON (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $20.00 General
Category: ENDOCRINOLOGY
12/08/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $17.27 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
12/06/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $17.91 General
Category: LIVER DISEASE
12/04/2024 Janssen Biotech, Inc. TREMFYA (Drug), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $18.25 General
Category: Immunology
11/18/2024 Intercept Pharmaceuticals, Inc. OCALIVA (Drug) Food and Beverage In-kind items and services $13.35 General
Category: Hepatology / Gastroenterology
11/15/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $16.31 General
Category: INTERNAL MEDICINE
11/13/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $125.00 General
Category: IMMUNOLOGY
11/13/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $18.50 General
Category: THERAPY FOR CSID
11/13/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $17.59 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
11/11/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $16.14 General
Category: THERAPY FOR CSID
11/04/2024 Merck Sharp & Dohme LLC DIFICID (Drug) Food and Beverage In-kind items and services $19.02 General
Category: INFECTIOUS DISEASE
11/01/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $18.31 General
Category: IMMUNOLOGY
10/30/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $18.10 General
Category: THERAPY FOR CSID
10/29/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $18.39 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
10/28/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $20.63 General
Category: THERAPY FOR CSID
10/23/2024 Janssen Biotech, Inc. TREMFYA (Drug), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $16.69 General
Category: Immunology
10/17/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $17.58 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
10/16/2024 Medtronic, Inc. INTERSTIM (Device) Food and Beverage In-kind items and services $16.81 General
Category: Sacral Nerve Stimulation
10/16/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $13.55 General
Category: Gastroenterology
10/14/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $18.90 General
Category: INFLAMMATION AND IMMUNOLOGY
10/14/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $16.46 General
Category: LIVER DISEASE
10/09/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $21.76 General
Category: Immunology
10/07/2024 Janssen Biotech, Inc. TREMFYA (Drug), SIMPONI, SIMPONI ARIA Food and Beverage In-kind items and services $16.52 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 313 373 $203,985 $32,078
2022 17 769 1,007 $611,760 $92,908
2021 2 61 93 $26,382 $6,985
Total Patients
1,143
Total Services
1,473
Medicare Billing
$131,971
Procedure Codes
29

All Medicare Procedures & Services

29 procedure records from CMS Medicare Utilization — Page 2 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 12 12 $14,520 $1,147 7.9%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 12 21 $2,604 $730.36 28.0%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 37 69 $15,870 $4,283 27.0%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 24 24 $10,512 $2,702 25.7%

About Dr. Shefali Shah, M.D

Dr. Shefali Shah, M.D is a Internal Medicine healthcare provider based in Oakhurst, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2015. The National Provider Identifier (NPI) number assigned to this provider is 1720469950.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shefali Shah, M.D has received a total of $3,392 in payments from pharmaceutical and medical device companies, with $1,685 received in 2024. These payments were reported across 168 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,256).

As a Medicare-enrolled provider, Shah has provided services to 1,143 Medicare beneficiaries, totaling 1,473 services with total Medicare billing of $131,971. Data is available for 3 years (2021–2023), covering 29 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Gastroenterology
  • Location Oakhurst, NJ
  • Active Since 06/12/2015
  • Last Updated 03/06/2025
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1720469950

Products in Payments

  • RINVOQ (Biological) $377.32
  • DUPIXENT (Biological) $343.30
  • XELJANZ (Drug) $256.54
  • SUCRAID (Drug) $221.42
  • ENTYVIO (Biological) $199.12
  • SKYRIZI (Biological) $157.32
  • TREMFYA (Drug) $152.62
  • XIFAXAN (Drug) $150.89
  • Barrx (Device) $125.00
  • INTERSTIM (Device) $116.67
  • STELARA (Biological) $99.00
  • EOHILIA (Drug) $97.52
  • DIFICID (Drug) $93.04
  • Kanuma (Drug) $89.77
  • CREON (Drug) $89.40
  • Sucraid (Drug) $78.66
  • ZEPOSIA (Drug) $71.20
  • VELSIPITY (Drug) $67.43
  • RESMETIROM (Drug) $67.03
  • LINZESS (Drug) $63.48

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Oakhurst